Methods of administering CRF antagonists
 Compounds of the formula ##STR1## wherein B, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are as defined herein with reference to formula IX have corticotropin-releasing factor antagonist activity and as such are of use in the treatment of panics, phobias and other stress-related disorders. 
Pfizer Inc.
A A A A A A A A A A A A A A A A A
A61P A61P A61P A61P A61K A61P A61K A61P A61P A61K A61P A61P A61K A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Gene M. Yuhpyng L. Willard M.
Bright Chen Welch